QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04)

Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, Hohenberger W, Arnold D, Hofheinz R, Ghadimi M, Raab H, Stroebel P, Staib L, Grabenbauer GG, Folprecht G, Uter W, Gall C, Roedel C, Polat B (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Radiotherapy and Oncology Elsevier

Publisher: ELSEVIER IRELAND LTD

City/Town: CLARE

Pages Range: S191-S192

Conference Proceedings Title: RADIOTHERAPY AND ONCOLOGY

Event location: Milan

DOI: 10.1016/s0167-8140(19)30804-7

Authors with CRIS profile

Rainer Fietkau Lehrstuhl für Strahlentherapie Werner Hohenberger Department of Surgery Wolfgang Uter Professur für Epidemiologie Christine Gall Lehrstuhl für Biometrie und Epidemiologie

Involved external institutions

Ruprecht-Karls-Universität Heidelberg

Germany (DE) Universitätsklinikum Würzburg

Germany (DE) Goethe-Universität Frankfurt am Main

Germany (DE) DiaCura - Praxis für Radiologische Diagnostik, Strahlentherapie und Radioonkologie

Germany (DE) Klinik für Tumorbiologie

Germany (DE) Kliniken Maria Hilf GmbH

Germany (DE) Carl von Ossietzky Universität Oldenburg

Germany (DE) Universitätsklinikum Göttingen

Germany (DE) Städtische Kliniken Esslingen

Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden

Germany (DE)

How to cite

APA:

Kosmala, R., Fokas, E., Flentje, M., Sauer, R., Liersch, T., Graeven, U.,... Polat, B. (2019). QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04). In RADIOTHERAPY AND ONCOLOGY (pp. S191-S192). Milan, IT: CLARE: ELSEVIER IRELAND LTD.

MLA:

Kosmala, R., et al. "QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04)." Proceedings of the 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan CLARE: ELSEVIER IRELAND LTD, 2019. S191-S192.

BibTeX: Download